
IN VITRO ANALYSIS OF AKR1D1 INTERACTIONS WITH CLOPIDOGREL: EFFECTS ON ENZYME ACTIVITY AND GENE EXPRESSION Shutevska K1*, Kadifkova Panovska T1, Zhivikj Z1, Kapedanovska Nestorovska A2 *Corresponding Author: *Corresponding Author: Kristina Shutevska, Majka Tereza 47, 1000 Skopje, Republic of North Macedonia, +389 2 1326032 (142), k.sutevska@ff.ukim.edu.mk page: 69
|
MATERIALS AND METHODS
Reagents and Chemicals
– Molecular Cloning Reagents:
l Full-length AKR1D1 cDNA (OriGene, Rockville,
MD, USA; Cat# RC223056): Used for amplify-
ing and cloning the AKR1D1 gene into an expres-
sion vector.
l pET28b+ vector (Novagen (Merck KGaA),
Darmstadt, Germany; Cat# 69865-3): Expression
vector used for recombinant protein production.
– Enzyme Assay Reagents:
l Testosterone (Sigma-Aldrich, St. Louis, MO,
USA; Cat# T1500): Substrate for AKR1D1 ac-
tivity assays.
l Clopidogrel Bisulfate (Sigma-Aldrich, St. Louis,
MO, USA; Cat# C0612): Evaluated for interac-
tions with AKR1D1 at both enzymatic and tran-
scriptional levels.
l 2-oxoclopidogrel (Cayman Chemical, Ann Ar-
bor, MI, USA; Cat# 20394): Metabolite of clopi-
dogrel tested for interactions with AKR1D1 at
both enzymatic and transcriptional levels.
– Cell Culture Reagents:
l HepG2 Hepatocyte Cell Line (ATCC, Manassas,
VA, USA; Cat# HB-8065): An in vitro model
system used to study AKR1D1 expression and
hepatic metabolism.
l Dulbecco’s Modified Eagle Medium (DMEM;
Sigma-Aldrich, St. Louis, MO, USA; Cat#
D6429): Basal medium for HepG2 cell mainte-
nance.
l Fetal Bovine Serum (FBS) (Capricorn Scientific,
Ebsdorfergrund, Germany; Cat# FBS-12A): Sup-
plemented in DMEM to support cell growth and
viability.
l Trypsin-EDTA Solution (Lonza, Walkersville,
MD, USA; Cat# CC-5012): Used for cell detach-
ment during subculturing.
– MTT Assay Reagents:
l MTT Solution (5 mg/mL) (Sigma-Aldrich, St.
Louis, MO, USA; Cat# M2128): Used to evaluate
cell viability through formazan crystal formation.
l Dimethyl Sulfoxide (DMSO) (Thermo Fisher
Scientific, Waltham, MA, USA; Cat# D12345):
Used to dissolve formazan crystals for spectro-
photometric analysis.
l NADPH (Sigma-Aldrich, St. Louis, MO, USA;
Cat# N7505): Essential cofactor for spectrofluo-
rometric enzyme activity assays.
–Expression Assay Reagents
l HpaI Restriction Enzyme (New England Biolabs,
Ipswich, MA, USA; Cat# R0105S): Used for
linearizing the AKR1D1 plasmid to generate a
calibration curve for qRT-PCR quantification.
l Shrimp Alkaline Phosphatase (Takara Bio, Shiga,
Japan; Cat# 2650A): Used for dephosphorylat-
ing the linearized plasmid DNA to prevent self-
ligation.
l TRI Reagent® (Sigma-Aldrich, St. Louis, MO,
USA; Cat# T9424): Used for total RNA extrac-
tion from HepG2 cells.
l ProtoScript® II Reverse Transcriptase (New Eng-
land Biolabs, Ipswich, MA, USA; Cat# M0368):
Used to synthesize complementary DNA (cDNA)
from isolated RNA.
l XCEED qPCR SG 2x Mix Lo-ROX (Institute of
Applied Biotechnologies, Prague, Czech Repub-
lic; Cat# QR0100): Used for quantitative real-
time PCR analysis of AKR1D1 gene expression.
l Forward and Reverse Primers (GeneriBiotech,
Hradec Králové, Czech Republic): Specific prim-
ers designed for the amplification of AKR1D1
during quantitative real-time PCR.
|
|
|
|



 |
Number 27 VOL. 27 (2), 2024 |
Number 27 VOL. 27 (1), 2024 |
Number 26 Number 26 VOL. 26(2), 2023 All in one |
Number 26 VOL. 26(2), 2023 |
Number 26 VOL. 26, 2023 Supplement |
Number 26 VOL. 26(1), 2023 |
Number 25 VOL. 25(2), 2022 |
Number 25 VOL. 25 (1), 2022 |
Number 24 VOL. 24(2), 2021 |
Number 24 VOL. 24(1), 2021 |
Number 23 VOL. 23(2), 2020 |
Number 22 VOL. 22(2), 2019 |
Number 22 VOL. 22(1), 2019 |
Number 22 VOL. 22, 2019 Supplement |
Number 21 VOL. 21(2), 2018 |
Number 21 VOL. 21 (1), 2018 |
Number 21 VOL. 21, 2018 Supplement |
Number 20 VOL. 20 (2), 2017 |
Number 20 VOL. 20 (1), 2017 |
Number 19 VOL. 19 (2), 2016 |
Number 19 VOL. 19 (1), 2016 |
Number 18 VOL. 18 (2), 2015 |
Number 18 VOL. 18 (1), 2015 |
Number 17 VOL. 17 (2), 2014 |
Number 17 VOL. 17 (1), 2014 |
Number 16 VOL. 16 (2), 2013 |
Number 16 VOL. 16 (1), 2013 |
Number 15 VOL. 15 (2), 2012 |
Number 15 VOL. 15, 2012 Supplement |
Number 15 Vol. 15 (1), 2012 |
Number 14 14 - Vol. 14 (2), 2011 |
Number 14 The 9th Balkan Congress of Medical Genetics |
Number 14 14 - Vol. 14 (1), 2011 |
Number 13 Vol. 13 (2), 2010 |
Number 13 Vol.13 (1), 2010 |
Number 12 Vol.12 (2), 2009 |
Number 12 Vol.12 (1), 2009 |
Number 11 Vol.11 (2),2008 |
Number 11 Vol.11 (1),2008 |
Number 10 Vol.10 (2), 2007 |
Number 10 10 (1),2007 |
Number 9 1&2, 2006 |
Number 9 3&4, 2006 |
Number 8 1&2, 2005 |
Number 8 3&4, 2004 |
Number 7 1&2, 2004 |
Number 6 3&4, 2003 |
Number 6 1&2, 2003 |
Number 5 3&4, 2002 |
Number 5 1&2, 2002 |
Number 4 Vol.3 (4), 2000 |
Number 4 Vol.2 (4), 1999 |
Number 4 Vol.1 (4), 1998 |
Number 4 3&4, 2001 |
Number 4 1&2, 2001 |
Number 3 Vol.3 (3), 2000 |
Number 3 Vol.2 (3), 1999 |
Number 3 Vol.1 (3), 1998 |
Number 2 Vol.3(2), 2000 |
Number 2 Vol.1 (2), 1998 |
Number 2 Vol.2 (2), 1999 |
Number 1 Vol.3 (1), 2000 |
Number 1 Vol.2 (1), 1999 |
Number 1 Vol.1 (1), 1998 |
|
|